Opdivo (Nivolumab) Offers Some Hope for a Deadly Lung Cancer

TUESDAY, April 4, 2017 — The cancer drug Opdivo (nivolumab) may offer hope of a longer life for some patients with advanced lung cancer, a new small study finds.
Currently, only about 5 percent of patients with advanced non-small-cell lung cancer…
Source: Topamax